On Tuesday, Abeona Therapeutics Inc (NASDAQ: ABEO) opened higher 3.05% from the last session, before settling in for the closing price of $6.23. Price fluctuations for ABEO have ranged from $3.93 to $7.32 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -15.07% over the last five years. Company’s average yearly earnings per share was noted 66.24% at the time writing. With a float of $45.20 million, this company’s outstanding shares have now reached $48.95 million.
The firm has a total of 136 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Abeona Therapeutics Inc (ABEO) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Abeona Therapeutics Inc is 11.64%, while institutional ownership is 59.05%. The most recent insider transaction that took place on May 16 ’25, was worth 45,440. In this transaction Director of this company sold 8,000 shares at a rate of $5.68, taking the stock ownership to the 92,435 shares. Before that another transaction happened on May 16 ’25, when Company’s Director proposed sale 8,000 for $5.68, making the entire transaction worth $45,423.
Abeona Therapeutics Inc (ABEO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 66.24% per share during the next fiscal year.
Abeona Therapeutics Inc (NASDAQ: ABEO) Trading Performance Indicators
Check out the current performance indicators for Abeona Therapeutics Inc (ABEO). In the past quarter, the stock posted a quick ratio of 4.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach 0.24 in one year’s time.
Technical Analysis of Abeona Therapeutics Inc (ABEO)
Analysing the last 5-days average volume posted by the [Abeona Therapeutics Inc, ABEO], we can find that recorded value of 1.5 million was better than the volume posted last year of 1.08 million. As of the previous 9 days, the stock’s Stochastic %D was 92.19%. Additionally, its Average True Range was 0.48.
During the past 100 days, Abeona Therapeutics Inc’s (ABEO) raw stochastic average was set at 73.37%, which indicates a significant increase from 66.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 87.23% in the past 14 days, which was higher than the 68.58% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.27, while its 200-day Moving Average is $5.63. Now, the first resistance to watch is $6.52. This is followed by the second major resistance level at $6.62. The third major resistance level sits at $6.80. If the price goes on to break the first support level at $6.24, it is likely to go to the next support level at $6.05. Should the price break the second support level, the third support level stands at $5.95.
Abeona Therapeutics Inc (NASDAQ: ABEO) Key Stats
There are currently 51,157K shares outstanding in the company with a market cap of 328.43 million. Presently, the company’s annual sales total 0 K according to its annual income of -63,730 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -12,030 K.
